Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012

Vaccine

Volumn 31, Issue 5, 2013, Pages 839-844

  King, James C ^a   Lichenstein, Richard ^a   Magder, Laurence S ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Influenza; Influenza vaccine; Medically attended acute respiratory illness

Indexed keywords

INFLUENZA VACCINE;

ABNORMAL RESPIRATORY SOUND; ACUTE OTITIS MEDIA; ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGED; ARTICLE; ASTHMA; ATELECTASIS; BRONCHIOLITIS; BRONCHITIS; COMMON COLD; CORRELATION ANALYSIS; CROUP; DYSPNEA; EMERGENCY WARD; EMPYEMA; EPIDEMIC; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; LUNG ABSCESS; MASTOIDITIS; MEDICALLY ATTENDED ACUTE RESPIRATORY ILLNESS; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SINUSITIS; STRIDOR; TACHYPNEA; TONSILLITIS; TRACHEITIS; UNITED STATES; WHEEZING;

AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MARYLAND; MIDDLE AGED; VACCINATION;

EID: 84872618254     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.054     Document Type: Article

References (26)

1. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., et al. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010. MMWR Recomm Rep 2010, 59:1-62.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N.J., Anderson L.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-1340.
3. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
4. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectivenss of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
5. Jefferson T., Rivetti D., Rudin M., Di Pietrantonj C., Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005, 366:1165-1174.
6. Jefferson T., Di Pietrantonj Al-Ansary L.A., Ferroni E., Thorning S., Thomas R.E. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, 17(2):CD004876.
7. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly, a quantitative review. Vaccine 2006, 24(8):1159-1169.
8. United States Surveillance Data: 1997-1998 through 2007-2008 Seasons. Available from [accessed 14.02.11]. http://www.cdc.gov/flu/weekly/ussurvdata.htm.
9. Centers for Disease Control and Prevention (CDC) Update: influenza activity-United States and worldwide, 2001-2002 season, and composition of the 2002-2003 influenza vaccine. MMWR Morb Mortal Wkly Rep 2002, 51:503-506.
10. Centers for Disease Control and Prevention (CDC) Update: influenza activity-United States and worldwide, 2002-2003 season, and composition of the 2003-2004 influenza vaccine. MMWR Morb Mortal Wkly Rep 2003, 52:516-521.
11. Centers for Disease Control and Prevention (CDC) Update: influenza activity-United States and worldwide, 2003-2004 season, and composition of the 2004-2005 influenza vaccine. MMWR Morb Mortal Wkly Rep 2004, 53:547-552.
12. Centers for Disease Control and Prevention (CDC) Update: influenza activity-United States and worldwide, 2004-2005 season. MMWR Morb Mortal Wkly Rep 2005, 54:631-634.
13. Centers for Disease Control and Prevention (CDC) Update: influenza activity-United States and worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine. MMWR Morb Mortal Wkly Rep 2006, 55:648-653.
14. Centers for Disease Control and Prevention (CDC) Update: influenza activity-United States and worldwide, 2006-2007 season, and composition of the 2007-2008 influenza vaccine. MMWR Morb Mortal Wkly Rep 2007, 56:789-794.
15. Centers for Disease Control and Prevention (CDC) Influenza activity-United States and worldwide, 2007-2008 season. MMWR Morb Mortal Wkly Rep 2008, 57:692-697.
16. Belongia E.A., Kieke B.A., Donahue J.G., Greenlee R.T., Balish A., Foust A., et al. Effectivenss of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009, 199:159-167.
17. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., et al. Effectiveness of cost-benefit of influenza vaccination of healthy working adults: a randomized trial. JAMA 2000, 284:1655-1663.
18. Kelly HA, Sullivan SG, Grant KA, Fielding JE. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2012. Influenza Other Respir Viruses; doi:10.1111/irv.12018.
19. Dean A.S., Moffatt C.R.M., Rosewell A., Dwyer D.E., Lindley R.I., Booy R., et al. Incompletely matched influenza vaccine still provides protection in frail elderly. Vaccine 2010, 28:864-867.
20. Maryland Behavioral Risk Factor Surveillance System - 2002-2009 results. Available from [accessed 11.02.11]. http://www.marylandbrfss.org/.
21. King J.C., Lichenstein R., Cummings G.E., Magder L.S. Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland. Vaccine 2010, 28:7737-7742.
22. Lichenstein R., Magder L.S., King R.E. The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period. J Infect Dis 2012, 206(6):821-827.
23. Piedra P.A., Gaglani M.J., Kozinetz C.K., Herschler G., Riggs M., Griffith M., et al. Herd immunity in adults against influenza-related illnesses with the use of trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005, 23(13):1540-1548.
24. ® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Vaccine 2012, 30(23):3470-3477.
25. Leroux-Roels I., Roman F., Forgus S., Maes C., De Boever F., Drame M., et al. Priming with ASO3 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised primary study. Vaccine 2010, 28(3):849-857.
26. Intercensal population by gender and age groups, July 1, 2004 resident population estimates. [accessed 29.05.12]. http://www.mdp.state.md.us/msdc/S2_estimate.Shtml.